Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: CAT

Gene summary for CAT

Gene summary.

Gene information	Species	Human
	Gene symbol	CAT
	Gene ID	847
	Gene name	catalase
	Gene Alias	CAT
	Cytomap	11p13
	Gene Type	protein-coding
	GO ID	GO:0000302
	UniProtAcc	P04040

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
847	CAT	HTA11_78_2000001011	Human	Colorectum	AD	2.00e-03	5.07e-01	-0.1088
847	CAT	HTA11_347_2000001011	Human	Colorectum	AD	3.90e-09	5.05e-01	-0.1954
847	CAT	HTA11_1391_2000001011	Human	Colorectum	AD	5.60e-05	6.23e-01	-0.059
847	CAT	HTA11_6801_2000001011	Human	Colorectum	SER	1.24e-03	8.69e-01	0.0171
847	CAT	HTA11_7696_3000711011	Human	Colorectum	AD	1.99e-07	3.86e-01	0.0674
847	CAT	HTA11_99999970781_79442	Human	Colorectum	MSS	2.54e-08	4.98e-01	0.294
847	CAT	HTA11_99999971662_82457	Human	Colorectum	MSS	1.80e-09	5.47e-01	0.3859
847	CAT	A015-C-203	Human	Colorectum	FAP	7.08e-08	-2.11e-01	-0.1294
847	CAT	A014-C-040	Human	Colorectum	FAP	1.14e-02	-3.22e-01	-0.1184
847	CAT	A002-C-201	Human	Colorectum	FAP	2.55e-07	-2.21e-01	0.0324
847	CAT	A001-C-119	Human	Colorectum	FAP	1.69e-02	-2.32e-01	-0.1557
847	CAT	A001-C-108	Human	Colorectum	FAP	4.25e-02	-1.98e-01	-0.0272
847	CAT	A002-C-205	Human	Colorectum	FAP	5.71e-08	-2.29e-01	-0.1236
847	CAT	A015-C-006	Human	Colorectum	FAP	2.24e-06	-2.79e-01	-0.0994
847	CAT	A015-C-106	Human	Colorectum	FAP	3.05e-03	-1.14e-01	-0.0511
847	CAT	A002-C-114	Human	Colorectum	FAP	2.00e-07	-2.52e-01	-0.1561
847	CAT	A015-C-104	Human	Colorectum	FAP	2.19e-06	-8.53e-02	-0.1899
847	CAT	A001-C-014	Human	Colorectum	FAP	1.39e-03	-2.30e-01	0.0135
847	CAT	A002-C-016	Human	Colorectum	FAP	2.38e-06	-2.14e-01	0.0521
847	CAT	A015-C-002	Human	Colorectum	FAP	1.48e-03	-2.53e-01	-0.0763

Page: 1 2 3 4 5 6 7 8

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Colorectum (GSE201348)		FAP: Familial adenomatous polyposis
		CRC: Colorectal cancer
Colorectum (HTA11)		AD: Adenomas
		SER: Sessile serrated lesions
		MSI-H: Microsatellite-high colorectal cancer
		MSS: Microsatellite stable colorectal cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Lung		AAH: Atypical adenomatous hyperplasia
		AIS: Adenocarcinoma in situ
		IAC: Invasive lung adenocarcinoma
		MIA: Minimally invasive adenocarcinoma
Oral Cavity		EOLP: Erosive Oral lichen planus
		LP: leukoplakia
		NEOLP: Non-erosive oral lichen planus
		OSCC: Oral squamous cell carcinoma
Skin		AK: Actinic keratosis
		cSCC: Cutaneous squamous cell carcinoma
		SCCIS:squamous cell carcinoma in situ
Thyroid		ATC: Anaplastic thyroid cancer
		HT: Hashimoto's thyroiditis
		PTC: Papillary thyroid cancer

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:004586210	Cervix	CC	positive regulation of proteolysis	95/2311	372/18723	1.84e-12	6.86e-10	95
GO:190589710	Cervix	CC	regulation of response to endoplasmic reticulum stress	27/2311	82/18723	9.24e-07	3.25e-05	27
GO:004887210	Cervix	CC	homeostasis of number of cells	61/2311	272/18723	2.17e-06	6.55e-05	61
GO:003497610	Cervix	CC	response to endoplasmic reticulum stress	57/2311	256/18723	5.81e-06	1.42e-04	57
GO:190357310	Cervix	CC	negative regulation of response to endoplasmic reticulum stress	17/2311	44/18723	8.57e-06	1.97e-04	17
GO:00507273	Cervix	CC	regulation of inflammatory response	75/2311	386/18723	3.95e-05	6.18e-04	75
GO:00069846	Cervix	CC	ER-nucleus signaling pathway	16/2311	46/18723	7.12e-05	9.90e-04	16
GO:00516048	Cervix	CC	protein maturation	56/2311	294/18723	5.90e-04	5.59e-03	56
GO:00321022	Cervix	CC	negative regulation of response to external stimulus	75/2311	420/18723	5.96e-04	5.61e-03	75
GO:0031348	Cervix	CC	negative regulation of defense response	48/2311	258/18723	2.30e-03	1.65e-02	48
GO:0006091	Colorectum	AD	generation of precursor metabolites and energy	209/3918	490/18723	3.17e-28	6.61e-25	209
GO:0009060	Colorectum	AD	aerobic respiration	108/3918	189/18723	9.14e-28	1.43e-24	108
GO:0045333	Colorectum	AD	cellular respiration	119/3918	230/18723	3.21e-25	4.02e-22	119
GO:0015980	Colorectum	AD	energy derivation by oxidation of organic compounds	143/3918	318/18723	2.78e-22	2.49e-19	143
GO:0009150	Colorectum	AD	purine ribonucleotide metabolic process	142/3918	368/18723	4.29e-15	1.17e-12	142
GO:0006163	Colorectum	AD	purine nucleotide metabolic process	149/3918	396/18723	1.08e-14	2.80e-12	149
GO:0072521	Colorectum	AD	purine-containing compound metabolic process	153/3918	416/18723	4.34e-14	1.01e-11	153
GO:0009259	Colorectum	AD	ribonucleotide metabolic process	144/3918	385/18723	5.25e-14	1.13e-11	144
GO:0019693	Colorectum	AD	ribose phosphate metabolic process	145/3918	396/18723	3.01e-13	5.71e-11	145
GO:0009117	Colorectum	AD	nucleotide metabolic process	168/3918	489/18723	2.20e-12	3.36e-10	168

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79

Enriched KEGG pathways.

Pathway ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	qvalue	Count
hsa05208114	Oral cavity	OSCC	Chemical carcinogenesis - reactive oxygen species	150/3704	223/8465	6.45e-13	1.20e-11	6.11e-12	150
hsa0406813	Oral cavity	OSCC	FoxO signaling pathway	85/3704	131/8465	7.50e-07	4.33e-06	2.21e-06	85
hsa0120015	Oral cavity	OSCC	Carbon metabolism	74/3704	115/8465	6.10e-06	3.05e-05	1.55e-05	74
hsa0421113	Oral cavity	OSCC	Longevity regulating pathway	54/3704	89/8465	9.24e-04	2.65e-03	1.35e-03	54
hsa0421313	Oral cavity	OSCC	Longevity regulating pathway - multiple species	38/3704	62/8465	3.97e-03	9.86e-03	5.02e-03	38
hsa0414611	Oral cavity	OSCC	Peroxisome	47/3704	82/8465	9.01e-03	2.01e-02	1.03e-02	47
hsa0501429	Oral cavity	LP	Amyotrophic lateral sclerosis	197/2418	364/8465	1.25e-25	1.39e-23	8.93e-24	197
hsa0502229	Oral cavity	LP	Pathways of neurodegeneration - multiple diseases	232/2418	476/8465	7.77e-22	3.69e-20	2.38e-20	232
hsa05208210	Oral cavity	LP	Chemical carcinogenesis - reactive oxygen species	119/2418	223/8465	3.00e-15	8.32e-14	5.37e-14	119
hsa0120022	Oral cavity	LP	Carbon metabolism	62/2418	115/8465	8.38e-09	1.39e-07	8.99e-08	62
hsa006305	Oral cavity	LP	Glyoxylate and dicarboxylate metabolism	15/2418	30/8465	1.05e-02	3.72e-02	2.40e-02	15
hsa0414621	Oral cavity	LP	Peroxisome	33/2418	82/8465	1.48e-02	4.69e-02	3.03e-02	33
hsa0501437	Oral cavity	LP	Amyotrophic lateral sclerosis	197/2418	364/8465	1.25e-25	1.39e-23	8.93e-24	197
hsa0502237	Oral cavity	LP	Pathways of neurodegeneration - multiple diseases	232/2418	476/8465	7.77e-22	3.69e-20	2.38e-20	232
hsa0520838	Oral cavity	LP	Chemical carcinogenesis - reactive oxygen species	119/2418	223/8465	3.00e-15	8.32e-14	5.37e-14	119
hsa0120032	Oral cavity	LP	Carbon metabolism	62/2418	115/8465	8.38e-09	1.39e-07	8.99e-08	62
hsa0063012	Oral cavity	LP	Glyoxylate and dicarboxylate metabolism	15/2418	30/8465	1.05e-02	3.72e-02	2.40e-02	15
hsa0414631	Oral cavity	LP	Peroxisome	33/2418	82/8465	1.48e-02	4.69e-02	3.03e-02	33

Page: 1 2 3 4 5 6 7

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand

Receptor

LRpair

Pathway

Tissue

Disease Stage

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

TF	Cell Type	Tissue	Disease Stage	Target Gene	RSS	Regulon Activity
CAT	AT2L	Lung	AAH	SFTPC,PEBP4,SFTPA1, etc.	2.44e-01
CAT	STM	Lung	AAH	SFTPC,PEBP4,SFTPA1, etc.	5.86e-02
CAT	AT2	Lung	AAH	SFTPC,PEBP4,SFTPA1, etc.	5.13e-01
CAT	AT2	Lung	ADJ	SFTPC,PEBP4,SFTPA1, etc.	4.58e-01
CAT	AT2	Lung	AIS	SFTPC,PEBP4,SFTPA1, etc.	3.84e-01
CAT	STM	Lung	AIS	SFTPC,PEBP4,SFTPA1, etc.	8.39e-02
CAT	AT2	Lung	MIAC	SFTPC,PEBP4,SFTPA1, etc.	3.21e-01

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

CAT

SNV

Missense_Mutation

rs573379158

c.1559N>T

p.Ala520Val

p.A520V

P04040

protein_coding

tolerated_low_confidence(0.11)

benign(0)

TCGA-E2-A153-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

doxorubicin

CAT

insertion

Nonsense_Mutation

novel

c.883_884insTGTATTCTATTATTTGAATTTTTACACTC

p.Asn295MetfsTer6

p.N295Mfs*6

P04040

protein_coding

TCGA-A8-A07L-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Chemotherapy

CAT

SNV

Missense_Mutation

rs756388518

c.385N>T

p.Pro129Ser

p.P129S

P04040

protein_coding

deleterious(0)

probably_damaging(1)

TCGA-2W-A8YY-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Chemotherapy

cisplatin

CAT

SNV

Missense_Mutation

rs573379158

c.1559C>T

p.Ala520Val

p.A520V

P04040

protein_coding

tolerated_low_confidence(0.11)

benign(0)

TCGA-EA-A3HU-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Unknown

CAT

SNV

Missense_Mutation

c.988N>A

p.Glu330Lys

p.E330K

P04040

protein_coding

deleterious(0)

probably_damaging(1)

TCGA-FU-A23K-01

Cervix

cervical & endocervical cancer

Female

<65

III/IV

Unknown

CAT

SNV

Missense_Mutation

c.415N>A

p.Glu139Lys

p.E139K

P04040

protein_coding

deleterious(0.01)

possibly_damaging(0.552)

TCGA-VS-A9UP-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Chemotherapy

cisplatin

CAT

SNV

Missense_Mutation

rs752948472

c.380N>A

p.Arg127Gln

p.R127Q

P04040

protein_coding

deleterious(0)

probably_damaging(0.999)

TCGA-AA-3984-01

Colorectum

colon adenocarcinoma

Female

<65

I/II

Unknown

CAT

SNV

Missense_Mutation

rs777189700

c.1145N>A

p.Arg382Gln

p.R382Q

P04040

protein_coding

tolerated(0.26)

benign(0.015)

TCGA-AZ-4313-01

Colorectum

colon adenocarcinoma

Female

<65

I/II

Unknown

CAT

SNV

Missense_Mutation

rs778007071

c.749N>T

p.Ala250Val

p.A250V

P04040

protein_coding

deleterious(0)

probably_damaging(1)

TCGA-AZ-6598-01

Colorectum

colon adenocarcinoma

Female

>=65

I/II

Unknown

CAT

SNV

Missense_Mutation

novel

c.468N>T

p.Arg156Ser

p.R156S

P04040

protein_coding

deleterious(0.02)

possibly_damaging(0.631)

TCGA-AG-3892-01

Colorectum

rectum adenocarcinoma

Female

<65

I/II

Unknown

Page: 1 2 3 4 5

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID	Symbol	Category	Interaction Types	Drug Claim Name	Drug Name	PMIDs
847	CAT	ENZYME, DRUGGABLE GENOME		EUK-189
847	CAT	ENZYME, DRUGGABLE GENOME		ethanol	ALCOHOL	25514903
847	CAT	ENZYME, DRUGGABLE GENOME		anthracyclines and related substances		19863340

Page: 1